Calling Inflation Reduction Act 'draconian,' Biogen CEO hints at lawsuit

Biogen is looking at following in Merck's footsteps by suing the federal government over the Inflation Reduction Act's drug-pricing provisions.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news